UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interpreting the LHC Higgs search results in the MSSM

Physics letters. B, 2012-03, Vol.710 (1), p.201-206

2012

Volltextzugriff (PDF)

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

European journal of cancer (1990), 2019-03, Vol.110, p.53-61

2019

Volltextzugriff (PDF)

1904 Chromosomal aberrations associated with lymphovascular invasion in breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S300-S300

2015

Volltextzugriff (PDF)

1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial

European journal of cancer (1990), 2015-09, Vol.51, p.S269-S269

2015

Volltextzugriff (PDF)

Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF

European journal of cancer (1990), 2010, Vol.46 (9), p.1580-1587

2010

Volltextzugriff (PDF)

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

The Lancet (British edition), 1992-12, Vol.340 (8832), p.1369-1373

1992

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified

Cancer letters, 2011, Vol.313 (2), p.145-153

2011

Volltextzugriff (PDF)

Identification of intermediate risk breast cancer patients with 1-3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis

Breast (Edinburgh), 2013-10, Vol.22 (5), p.643-649

2013

Volltextzugriff (PDF)

Identification of intermediate risk breast cancer patients with1–3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis

Breast (Edinburgh), 2013, Vol.22 (5), p.643-649

2013

Volltextzugriff (PDF)

Effects of adjuvant tamoxifen over three decades on breast cancerefree and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial

European journal of cancer (1990), 2019-03, Vol.110, p.53

2019

Volltextzugriff (PDF)

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer

European journal of cancer (1990), 1995, Vol.31 (13), p.2185-2190

1995

Volltextzugriff (PDF)

Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy

Breast (Edinburgh), 2023-10, Vol.71, p.63-68

2023

Volltextzugriff (PDF)

Flow cytometric gating on cytokeratin-containing DNA aneuploid breast cancer cells improves the prediction of recurrence

European journal of cancer (1990), 1995-10, Vol.31 (11), p.1893-1895, Article 1893

1995

Volltextzugriff (PDF)

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

European journal of cancer (1990), 1994, Vol.30 (2), p.175-180

1994

Volltextzugriff (PDF)

5011 ORAL Assessments of Proliferation in Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S333-S333

2011

Volltextzugriff (PDF)

p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer

Radiotherapy and oncology, 1999-05, Vol.51 (2), p.169-174

1999

Volltextzugriff (PDF)

Mitochondrial regulation of cell cycle progression through SLC25A43

Biochemical and biophysical research communications, 2016-01, Vol.469 (4), p.1090-1096

2016

Volltextzugriff (PDF)

Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer

International journal of radiation oncology, biology, physics, 2001-07, Vol.50 (3), p.659-663

2001

Volltextzugriff (PDF)

Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases

Gynecologic oncology, 1998-01, Vol.68 (1), p.54-61

1998

Volltextzugriff (PDF)

Intact Mre11/Rad50/Nbs1 Complex Predicts Good Response to Radiotherapy in Early Breast Cancer

International journal of radiation oncology, biology, physics, 2007-05, Vol.68 (1), p.50-58

2007

Volltextzugriff (PDF)

Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer

European journal of cancer (1990), 2013-04, Vol.49 (6), p.1196-1204

2013

Volltextzugriff (PDF)

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

European journal of cancer (1990), 2005, Vol.41 (2), p.256-264

2005

Volltextzugriff (PDF)

Interval cancers and cancers in non-attenders in the östergötland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence

European journal of cancer (1990), 1997-08, Vol.33 (9), p.1453-1460

1997

Volltextzugriff (PDF)

Malignant Mixed Müllerian Tumors of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 44 Cases

Gynecologic oncology, 1998-01, Vol.68 (1), p.18-24

1998

Volltextzugriff (PDF)

ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma

European journal of cancer & clinical oncology, 1991, Vol.27 (12), p.1646-1649

1991

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(37)
Tagungsberichte
(2)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Humans
(24)
Oncology
(20)
Female
(19)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Medicin Och Hälsovetenskap
(14)
Middle Aged
(13)
Adult
(11)
Tumors
(11)
Aged
(9)
Medicin
(9)
Medicine
(9)
Prognosis
(9)
Dna, Neoplasm - Analysis
(8)
Hematology, Oncology And Palliative Medicine
(8)
Male
(8)
Breast Neoplasms - Drug Therapy
(6)
Breast Neoplasms - Pathology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interpreting the LHC Higgs search results in the MSSM

Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial

1904 Chromosomal aberrations associated with lymphovascular invasion in breast cancer

1812 Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival. Retrospective analyses of the STO3 randomizedtrial

Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF

Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma

Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified

Identification of intermediate risk breast cancer patients with 1-3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis

Identification of intermediate risk breast cancer patients with1–3 positive lymph nodes and excellent survival after tamoxifen as only systemic adjuvant therapy by use of markers of proliferation and apoptosis

Effects of adjuvant tamoxifen over three decades on breast cancerefree and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial

c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer

Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy

Flow cytometric gating on cytokeratin-containing DNA aneuploid breast cancer cells improves the prediction of recurrence

Cellular accumulation of p53 protein: an independent prognostic factor in stage II breast cancer

5011 ORAL Assessments of Proliferation in Breast Cancer

p53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer

Mitochondrial regulation of cell cycle progression through SLC25A43

Decreased tumor cell proliferation as an indicator of the effect of preoperative radiotherapy of rectal cancer

Leiomyosarcoma of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 49 Cases

Intact Mre11/Rad50/Nbs1 Complex Predicts Good Response to Radiotherapy in Early Breast Cancer

Akt2 expression is associated with good long-term prognosis in oestrogen receptor positive breast cancer

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

Interval cancers and cancers in non-attenders in the östergötland mammographic screening programme. Duration between screening and diagnosis, S-phase fraction and distant recurrence

Malignant Mixed Müllerian Tumors of the Uterus: A Clinicopathologic, DNA Flow Cytometric, p53, and mdm-2 Analysis of 44 Cases

ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma

Aktive Filter

Suchergebnisse filtern